Indaptus Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.29

-0.56 (-14.55%)

As of Sep 28, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,139.2% upside

Low Target $30.54

Average Target $40.77

High Target $54.50

Current Price $3.29

Current
$3.29

Target
$40.77

$30.54 $40.77 avg $54.50

Scenario Analysis

Bear Case

$30.54

828.3%

Low target

Base Case

$40.77

+1,139.2%

Avg target

Bull Case

$54.50

+1,556.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$8.57

-61.6% from high

52-Week Low

$0.92

+257.6% from low

Target vs 52W High

$40.77

+375.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%